---
title: The Embedded Participant During High-fidelity Simulation
nct_id: NCT04898660
overall_status: COMPLETED
sponsor: Claude Bernard University
study_type: OBSERVATIONAL
primary_condition: Healthy
countries: France
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04898660.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04898660"
ct_last_update_post_date: 2022-11-08
last_seen_at: "2026-05-12T06:55:12.885Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# The Embedded Participant During High-fidelity Simulation

**Official Title:** The Role of the Embedded Participant on Learners' Performance During High- Fidelity Simulation

**NCT ID:** [NCT04898660](https://clinicaltrials.gov/study/NCT04898660)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 340
- **Lead Sponsor:** Claude Bernard University
- **Conditions:** Healthy
- **Start Date:** 2021-09-01
- **Completion Date:** 2022-11-04
- **CT.gov Last Update:** 2022-11-08

## Brief Summary

Simulation in medicine is a powerful and effective teaching tool that has become essential for the training of students and health professionals.

In this context, simulation instructor training have been implemented in recent years, where many subjects are addressed, such as the main principles of pedagogy, the integration of simulation, the construction of a scenario, briefing and debriefing.

However, scenario facilitation, in particular the role of the embedded participant (EP), is only vaguely discussed. The EP of a high-fidelity simulation session plays a very important role in driving the scenario. Indeed, he/she guides the learner in order to achieve all the educational objectives set by the main instructor of the scenario. He/she also manages unexpected behavior and possible technical issues that may arise. Finally, the EP supervises the physical and psychological risks inherent in the simulation in order to maintain a safe environment.

All of these key roles suggest that the EP can influence the performance of the learners. Little is known about the relationship between Facilitation and Learner Performance.

In this observational study, investigators aim to explore the influence of the embedded participant on learners' technical and non-technical performances during high-fidelity simulation by analysing previously recorded sessions.

## Detailed Description

In this observational study, investigators aim to measure performance on high-fidelity simulation scenarios (HFS) used routinely in the current anesthesiology, training curriculum. Age, sex, previous experience of HFS will be noted. All data will be anonymized.

Two investigators will independently evaluate the performance of HFS by video record:

* technical performance on tables pre-established by experienced instructors and based on international recommendations,
* non-technical performances, assessed using the Ottawa Global Rating Scale.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 100 Years
- **Sex:** ALL

```
Inclusion Criteria:

* Resident physicians in anesthesia/intensive care- postgraduate year 1-5 participating in HFS training sessions from 2015 to 2021
* Consent for recording

Exclusion Criteria:

* Denial to be recorded
```

## Primary Outcomes

- **Technical Skills Performance** _(time frame: 1 month (review video))_ — technical performance on a scale pre-established according to each scenario rated from 0 to 100.
- **Non-technical skills performance** _(time frame: 1 month (review video))_ — Ottawa Crisis Resource Management Global Rating Scale rated from 6 to 42.

## Secondary Outcomes

- **Demographic characteristics** _(time frame: 1 month (collect data))_

## Locations (1)

- Claude Bernard University, Lyon, France

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.claude bernard university|lyon||france` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04898660.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04898660*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*